Elekta introduces AI-powered adaptive CT-Linac
Elekta’s Evo aims to achieve more accurate targeting, diminish side effects, and enhance cancer patients’ quality of life. Credit: Elekta. Elekta has launched the artificial intelligence (AI)-powered linear accelerator (linac), named Evo, offering advanced cancer treatment options. The CT-Linac is equipped with high-definition imaging and is designed to deliver both offline and online adaptive radiation […]
Angle signs AstraZeneca deal to develop prostate cancer assay
There are more than 130 active, interventional oncology clinical studies in 30,000 participants, which include androgen receptor assessment, registered on clinicaltrials.gov. Credit: Shutterstock/Peakstock UK liquid biopsy company, Angle, has agreed a supplier agreement with AstraZeneca to develop a Parsotix-based Androgen Receptor (AR) assay for use in prostate cancer studies. Angle’s Parsotix system captures and harvests […]
Karius secures $100m in Series C funding round
The funding will also support research into Karius’ microbial cell-free DNA technology beyond infectious diseases. Credit: Juraj Varga from Pixabay. US-based life science company Karius has secured $100m in Series C funding, which was co-led by Khosla Ventures, 5AM Ventures, and Gilde Healthcare. New investor Seventure Partners joined existing investors Softbank Vision Fund 2, HBM […]
MMI pioneers Symani Surgical System in first US cases
The total surgical robotics market is forecast to generate $10.3bn in 2030, according to GlobalData. Credit: Dana Neely via Getty Images. Medical Microinstruments (MMI) has announced the completion of its first two clinical cases in the US using the FDA-approved Symani Surgical System. The first two US procedures were reconstructive extremity microsurgeries conducted at Penn […]
Innosphere starts paediatric clinical trial for Novostim ADHD device
Innosphere’s Novostim 2 is a transcranial random noise stimulation (tRNS) device designed as a treatment for paediatric ADHD. Image Credit: Berit Kessler / Shutterstock. German device company Innosphere Engineering has started recruitment for the clinical trial for its attention deficit hyperactivity disorder (ADHD) device, Novostim 2. The randomised, sham-controlled trial will evaluate the Novostim 2 […]
Cytovale’s sepsis diagnostic test demonstrates 97.5% NPV in latest study
The IntelliSep technology enables quick diagnosis of sepsis for adults by squeezing white blood cells to characterise their responses to infection. Credit: Pixel-Shot via Shutterstock. Medical diagnostics company Cytovale has announced the publication of data that shows its sepsis diagnostics tool IntelliSep has a negative predictive value of 97.5%. The FDA-cleared IntelliSep technology enables quick […]
SonoVascular partners with Lantheus for VTE treatment
SonoVascular will have the option to secure a long-term exclusive commercial supply agreement with Lantheus. Credit: Yuliya Alekseeva/Shutterstock.com. SonoVascular has announced an exclusive clinical supply agreement with Lantheus for the use of the latter’s microbubbles in conjunction with the SonoThrombectomy System to treat venous thromboembolism (VTE). This agreement marks a significant step in the development […]
Aisap’s AI ultrasound tool secures $13m in seed funding
Aisap says the device uses deep learning AI capabilities to enable accurate readings even with lower-quality images. Credit: Shutterstock / Peakstock. Israeli artificial intelligence (AI) company, Aisap, has raised $13m in seed funding to propel to market its Point-of-Care Assisted Diagnosis (POCAD) device aimed at simplifying ultrasound procedures so that they can be read by […]
The evolution of medical device coatings
Finding the right coatings is crucial for advanced new medical devices. Credit: karegg via Shutterstock. Effective coatings are essential for medical devices in not only performance but also in complying with increasing regulations and environmental considerations. When the regulations change or new information comes to light about the effects of chemicals on human health or the environment, replacements are required that may initially be difficult […]
NovaScan selects Epredia to distribute MarginScan device in US
MarginScan utilises electrical assessment to confirm cancer-free margins. Credit: Epredia/Business Wire. NovaScan, a cancer detection technology developer, has entered a letter of intent with Epredia for the exclusive distribution of the MarginScan device in the US. MarginScan is aimed at enhancing real-time detection of non-melanoma skin cancer. The anticipated launch is set for next year, […]